Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Michael Reed

Thoracic Surgery (Cardiothoracic Vascular Surgery) Hershey, PA Medical Doctor

NPI 1447228069 CMS profile 156123

500 University Dr, Hershey, PA 17033

Open in the dashboard

General payments

$30,348

51 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$66,869 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Michael Reed of Hershey, PA is reported in the CMS Open Payments database as having received $30,348 across 51 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $66,869 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 85th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $7,025 15
2024 General $103 1
2023 General $1,581 7
2021 General $16,449 21
2020 General $5,111 4
2019 General $79 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Reed
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Michael Reed were reported at $7,025. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Michael Reed Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $79 $886 $178–$3,167 $163
2020 $5,111 $341 $108–$1,605 $114
2021 $16,449 $453 $125–$1,886 $132
2022 $0 $695 $180–$2,566 $149
2023 $1,581 $745 $205–$2,662 $160
2024 $103 $799 $214–$2,967 $164
2025 $7,025 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Gyrus ACMI, Inc. $19,677 23 payments
  2. Intuitive Surgical, Inc. $6,965 15 payments
  3. Olympus America Inc. $1,845 1 payment
  4. Medical Device Business Services, Inc. $1,388 4 payments
  5. Ethicon Inc. $163 2 payments
  6. Medtronic, Inc. $103 1 payment
  7. Caris MPI, Inc. $91 1 payment
  8. Atricure, Inc. $76 2 payments
  9. Pulmonx Corporation $38 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $18,143 10 payments
  2. Education $5,000 2 payments
  3. Travel and Lodging $4,491 17 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,845 1 payment
  5. Food and Beverage $869 21 payments
Products named General payments · program years 2019–2025
  1. Da Vinci Surgical System $4,465 14 payments
  2. DA VINCI SP $2,500 1 payment
  3. Spiration Valve System EndoTherapy $1,845 2 payments
  4. Spiration Valve System EndoTherapy Products $1,845 1 payment
  5. NA $1,388 4 payments
  6. Monarch Platform $163 2 payments
  7. COREVALVE EVOLUT R $103 1 payment
  8. MI CANCER SEEK $91 1 payment
  9. ATRICLIP LAA EXCLUSION SYSTEM $76 2 payments
  10. Pulmonx Endobronchial Valve EBV $38 2 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

97

Median for Thoracic Surgery: 42

Drug cost

$664

Median for Thoracic Surgery: $318

Branded share of claims

16.5%

Median for Thoracic Surgery: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 49 $529
Clopidogrel Clopidogrel Bisulfate Brand 16 $86
Tamsulosin Hcl Generic 32 $49

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 910 Part D prescribers listed as Thoracic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 29 billing codes

Paid by Medicare

$23,971

Medicare's payments for the services billed

Medicare patients

41

Average age 72

Services billed

93

22 women, 19 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Cancer 51%
Arthritis 49%
COPD 46%
Ischemic heart disease 37%
Diabetes 32%
Atrial fibrillation 29%
Chronic kidney disease 29%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

51 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record